PALI - Palisade Bio Inc
IEX Last Trade
3.55
-0.050 -1.408%
Share volume: 4,044
Last Updated: Fri 30 Aug 2024 06:12:43 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.60
-0.05
-1.39%
Fundamental analysis
17%
Profitability
0%
Dept financing
4%
Liquidity
75%
Performance
23%
Performance
5 Days
2.92%
1 Month
0.57%
3 Months
-23.43%
6 Months
-40.57%
1 Year
-67.13%
2 Year
-97.16%
Key data
Stock price
$3.55
DAY RANGE
N/A - N/A
52 WEEK RANGE
$3.30 - $28.95
52 WEEK CHANGE
-$0.64
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Kenneth Carter
Region: US
Website: https://senecabio.com/
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://senecabio.com/
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Recent news